secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001104659-24-066056
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics issues $700M in 2.50% convertible notes due 2029; used to repurchase 2026 notes and repay revolver
--------------------------------------------------------------------------------

- Issued $700M (incl. $100M greenshoe) of 2.50% Convertible Senior Notes due June 1, 2029.
- Used proceeds to repurchase $200M of 0% 2026 notes for $185.5M and repay $230M revolver balance.
- Entered capped call transactions costing ~$88.2M with cap price $180.18 (100% premium over stock).
- Initial conversion rate 8.5385 shares/$1,000 (~$117.12/share); notes redeemable from June 2027 if stock exceeds 130% of conversion price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000110465924066056/0001104659-24-066056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000110465924066056/tm2415643d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-066056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer